Aurinia Pharmaceuticals Inc. Gains 23.14%
Fri, Aug 06, 2021 at 05:33 PM
Aurinia Pharmaceuticals Inc. (AUPH:NASDAQ) shot up at $14.42, a gain of 23.1%. The stock got featured on our News Catalysts scanner on Thu, Aug 05, 2021 at 05:02 PM in the 'EARNINGS' category. From Thu, Jul 22, 2021, the stock recorded 30.00% Up Days and 27.27% Green Days
The stock spiked on Thu, Jul 29, 2021 at $14.76 with a volume of 6M+, and its share price has been moving sideways in recent weeks.
About Aurinia Pharmaceuticals Inc. (AUPH:NASDAQ)
Aurinia Pharmaceuticals Inc is a clinical stage pharmaceutical company. The Company is engaged in the development of a therapeutic drug to treat autoimmune diseases, in particular lupus nephritis.
Top 10 Gainers:
- GPCO (GPCO:NASDAQ), 1063.83%
- Kaixin Auto Holdings (KXIN:NASDAQ), 89.22%
- Sphere 3D Corp. (ANY:NASDAQ), 41.28%
- Westport Fuel Systems Inc. (WPRT:NASDAQ), 28.39%
- SCWorx Corp. (WORX:NASDAQ), 26.27%
- BeyondSpring Inc. (BYSI:NASDAQ), 23.82%
- Aurinia Pharmaceuticals Inc. (AUPH:NASDAQ), 23.14%
- LiveRamp Holdings, Inc. (RAMP:NYSE), 22.25%
- Future FinTech Group Inc. (FTFT:NASDAQ), 20.75%
- Switch, Inc. (SWCH:NYSE), 19.74%